Product correctly added to cart.

discount label
Semaxinib
View 3D

Targetmol logo

Semaxinib

CAS: 204005-46-9

Ref. TM-T2064

5mg
52.00 €
10mg
66.00 €
25mg
117.00 €
50mg
164.00 €
100mg
220.00 €
Estimated delivery in United States, on Tuesday 14 Jan 2025

Product Information

Name:
Semaxinib
Synonyms:
  • SU5416
  • (3Z)-3-[(3,5-dimethyl-1H-pyrrol-2-yl)methylidene]-1,3-dihydro-2H-indol-2-one
  • (3Z)-3-[(3,5-dimethyl-1H-pyrrol-2-yl)methylidene]-1H-indol-2-one
  • (Z)-3-(3,5-Dimethylpyrrol-2-ylmethylene)indolin-2-one
  • 2H-Indol-2-one, 3-[(3,5-dimethyl-1H-pyrrol-2-yl)methylene]-1,3-dihydro-
  • 3-((2,4-Dimethylpyrrol-5-YL)METHYLIDENYL)-2-indolonone
  • 3-(3,5-Dimethyl-1H-pyrrol-2-ylmethylene)-1,3-dihydroindol-2-one
  • 3-[(3,5-Dimethyl-1H-pyrrol-2-yl)methylene]-1,3-dihydro-2H-indol-2-one
  • 3-[(3,5-Dimethylpyrrol-2-yl)methylene]indolin-2-one
  • Nsc-696819
  • See more synonyms
  • Semaxanib
  • Semoxind
  • Su-5416
  • Sugen 5416
  • Tsu-16
  • VEGFR2 receptor tyrosine kinase III
Description:

Semaxinib (SU5416): potent VEGFR2 inhibitor, 20x more selective over PDGFRβ, not active on InsR/EGFR/FGFR, blocks ATP on VEGFR2, may reduce tumor vessels.

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Targetmol
Long term storage:
Notes:

Chemical properties

Molecular weight:
238.28
Formula:
C15H14N2O
Purity:
99.84%
Color/Form:
Yellow To Yellow Orange
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: TM-T2064 Semaxinib

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".